DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fa6678/orthobiologics_g) has announced the addition of GlobalData 's new report "Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" to their offering.
Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 provides key data, information and analysis on the global orthobiologics market. The report provides market landscape, competitive landscape and market trends information on the orthobiologics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts
Orthobiologics Market is Forecast to Reach $7.6 billion by 2017 The global orthobiologics market was valued at $4.8 billion in 2010, and is forecast to grow at a compound annual growth rate (CAGR) of 6.8% to reach $7.6 billion in 2017. The market is expected to be driven by a rapid increase in the elderly population, an increase in the prevalence of arthritis, technological innovations, the increasing number of spinal fusion surgeries and the increase in the trend of medical tourism.
The US Remains the Largest Orthobiologics Market Driven by an Increasingly Active Elderly Population and an Increasing Number of Spinal Fusion Surgeries
The US orthobiologics market was valued at $2.8 billion in 2010 and is expected to grow at a CAGR of 6.6% to reach $4.4 billion by 2017. The market growth is expected to be fuelled by a number of factors, such as an active elderly population, the uptake of orthopedic surgery at an earlier age, bone related problems due to the increasing incidence of obesity, the development of better and longer-lasting orthobiologic products, and new procedures, in particular, minimally-invasive procedures. Read more inside this comprehensive new report
Companies Mentioned:
- Medtronic, Inc.
- DePuy, Inc.
- Genzyme Corporation
- Synthes, Inc.
For more information visit http://www.researchandmarkets.com/research/fa6678/orthobiologics_g